Aromatase and regulation of the estrogen-to-androgen ratio in synovial tissue inflammation: Common pathway in both sexes

Annals of the New York Academy of Sciences

Volumn 1317, Issue 1, 2014, Pages 24-31

  Capellino, Silvia ^a   Straub, Rainer H ^b   Cutolo, Maurizio ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Androgens; Aromatase; Arthritis; Estrogens; Synovial inflammation

Indexed keywords

ANDROGEN; AROMATASE; AROMATASE INHIBITOR; CYTOKINE; ESTROGEN; MELATONIN; SEX HORMONE; TESTOSTERONE; VITAMIN D;

ARTHRALGIA; ARTICLE; CHRONIC INFLAMMATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IMMUNE RESPONSE; INFLAMMATION; MACROPHAGE; METABOLIC REGULATION; MOLECULAR BIOLOGY; NONHUMAN; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SEX; SYNOVIAL FLUID; SYNOVIUM;

ANDROGENS; AROMATASE; ARTHRITIS; ESTROGENS; SYNOVIAL INFLAMMATION;

ANDROGENS; ANIMALS; ANTIRHEUMATIC AGENTS; AROMATASE; AROMATASE INHIBITORS; ARTHRITIS, RHEUMATOID; ESTROGENS; HUMANS; IMMUNITY, CELLULAR; SYNOVIAL MEMBRANE; VITAMIN D;

EID: 84901480922     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/nyas.12398     Document Type: Article

References (45)

1. MacGregor, A.J. & A.J. Silman 1993. Epidemiological approaches to the immunogenetics of autoimmune rheumatic disease. Ann. Rheum. Dis. 52: 310-313.
2. Symmons, D. 2002. The prevalence of rheumatoid arthritis in the United Kingdom: new estimates for a new century. Rheumatology 41: 793-800.
3. Tengstrand, B., M. Ahlmén & I. Hafström 2004. The influence of sex on rheumatoid arthritis: a prospective study of onset and outcome after 2 years. J. Rheumatol. 31: 214-222.
4. Tengstrand, B., K. Carlström, L. Felländer-Tsai, et al. 2003. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J. Rheumatol. 30: 2338-2343.
5. Straub, R.H. 2007. The complex role of estrogens in inflammation. Endocr. Rev. 28: 521-574.
6. Carlsten, H., N. Nilsson, R. Jonsson, et al. 1992. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol. 144: 190-202.
7. Straub, R.H., J.W.J. Bijlsma, A. Masi, et al. 2013. Role of neuroendocrine and neuroimmune mechanisms in chronic inflammatory rheumatic diseases-the 10-year update. Semin. Arthritis Rheum. 43: 392-404.
8. Dubey, R.K., B. Imthurn, M. Barton, et al. 2005. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 66: 295-306.
9. + T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum. 36: 1087-1097.
10. Ishizuka, M., M. Hatori, T. Suzuki, et al. 2004. Sex steroid receptors in rheumatoid arthritis. Clin. Sci. (Lond.). 106: 293-300.
11. Capellino, S., B. Riepl, L. Rauch, et al. 2007. Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation? Ann. Rheum. Dis. 66: 53-58.
12. Carruba, G., P. D'Agostino, M. Miele, et al. 2003. Estrogen regulates cytokine production and apoptosis in PMA-differentiated, macrophage-like U937 cells. J. Cell. Biochem. 90: 187-196.
13. Schmidt, M., R. Hartung, S. Capellino, et al. 2009. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis. Arthritis Rheum. 60: 2913-2922.
14. Li, Z.G., V.A. Danis & P.M. Brooks 1993. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin. Exp. Rheumatol. 11: 157-162.
15. Cutolo, M., S. Accardo, B. Villaggio, et al. 1995. Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages. Mediators Inflamm. 4: 138-143.
16. Kanda, N., T. Tsuchida & K. Tamaki 1997. Testosterone suppresses anti-DNA antibody production in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Arthritis Rheum. 40: 1703-1711.
17. Keller, E.T., C. Chang & W.B. Ershler 1996. Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter. J. Biol. Chem. 271: 26267-26275.
18. Deighton, C.M., M.J. Watson & D.J. Walker 1992. Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs. J. Rheumatol. 19: 1663-1667.
19. Sambrook, P.N., J.A. Eisman, G.D. Champion, et al. 1988. Sex hormone status and osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum. 31: 973-978.
20. Cutolo, M., E. Balleari, M. Giusti, et al. 1991. Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum. 34: 1-5.
21. Booji, A., C.M. Biewenga-Booji, O. Huber-Bruning, et al. 1996. Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann. Rheum. Dis. 55: 811-815.
22. Giltay, E.J., D. van Schaardenburg, L.J. Gooren, et al. 1998. Effects of dehydroepiandrosterone administration on disease activity in patients with rheumatoid arthritis. Br. J. Rheumatol. 37: 705-706.
23. Hall, G.M., J.P. Larbre, T.D. Spector, et al. 1996. A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br. J. Rheumatol. 35: 568-573.
24. Auci, D.L., C.L. Reading & J.M. Frincke 2009. 7-Hydroxy androstene steroids and a novel synthetic analogue with reduced side effects as a potential agent to treat autoimmune diseases. Autoimmun. Rev. 8: 369-372.
25. Straub, R.H., L. Paimela, R. Peltomaa, et al. 2002. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum. 46: 654-662.
26. Masi, A.T., R.T. Chatterton & J.C. Aldag 1999. Perturbations of hypothalamic-pituitary-gonadal axis and adrenal androgen functions in rheumatoid arthritis: an odyssey of hormonal relationships to the disease. Ann. N. Y. Acad. Sci. 876: 53-62.
27. Weidler, C., P. Härle, J. Schedel, et al. 2004. Patients with rheumatoid arthritis and systemic lupus erythematosus have increased renal excretion of mitogenic estrogens in relation to endogenous antiestrogens. J. Rheumatol. 31: 489-494.
28. Castagnetta, L.A., G. Carruba, O.M. Granata, et al. 2003. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J. Rheumatol. 30: 2597-2605.
29. Schmidt, M., C. Weidler, H. Naumann, et al. 2005. Androgen conversion in osteoarthritis and rheumatoid arthritis synoviocytes-androstenedione and testosterone inhibit estrogen formation and favor production of more potent 5alpha-reduced androgens. Arthritis Res. Ther. 7: R938-48.
30. Straub, R.H., K. Stark, M. Schmidt, et al. 2013. Influence of CYB5A gene variants on risk of rheumatoid arthritis and local endocrine function in the joint. Brain Behav. Immun. 29: S12-S13.
31. Simpson, E.R., C. Clyne, G. Rubin, et al. 2002. Aromatase-a brief overview. Annu. Rev. Physiol. 64: 93-127.
32. Herrmann, M., J. Scholmerich & R.H. Straub 2002. Influence of cytokines and growth factors on distinct steroidogenic enzymes in vitro: a short tabular data collection. Ann. N. Y. Acad. Sci. 966: 166-186.
33. Azenaborm, A.A., P. Kennedy & S. Balistreri 2007. Chlamydia trachomatis infection of human trophoblast alters estrogen and progesterone biosynthesis: an insight into role of infection in pregnancy sequelae. Int. J. Med. Sci. 4: 223-231.
34. Parker, C.R. & G.D. Wendel 1988. The effects of syphilis on endocrine function of the fetoplacental unit. Am. J. Obstet. Gynecol. 159: 1327-1331.
35. Shimizu, I., N. Kohno, K. Tamaki, et al. 2007. Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection. World J. Gastroenterol. 13: 4295-4305.
36. Shanmugam, V.K., J. McCloskey, B. Elston, et al. 2012. The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms. Breast Cancer Res. Treat. 131: 699-708.
37. Burstein, H.J. 2007. Aromatase inhibitor-associated arthralgia syndrome. Breast 16: 223-234.
38. Felson, D.T. & S.R. Cummings 2005. Aromatase inhibitors and the syndrome of arthralgias with estrogen deprivation. Arthritis Rheum. 52: 2594-2598.
39. Bertolini, E., H. Letho-Gyselinck, C. Prati, et al. 2011. Rheumatoid arthritis and aromatase inhibitors. Joint Bone Spine. 78: 62-64.
40. Burk, R. 2008. Aromatase inhibitor-induced joint pain: melatonin's role. Med. Hypotheses. 71: 862-867.
41. Cutolo, M., K. Otsa, K. Laas, et al. 2006. Circannual vitamin d serum levels and disease activity in rheumatoid arthritis: Northern versus Southern Europe. Clin. Exp. Rheumatol. 24: 702-704.
42. Villaggio, B., S. Soldano & M. Cutolo 2012. 1, 25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin. Exp. Rheumatol. 30: 934-938.
43. Cutolo, M., B. Villaggio, B. Seriolo, et al. 2004. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun. Rev. 3: 193-198.
44. Josefsson, E. & A. Tarkowski 1997. Suppression of type II collagen-induced arthritis by the endogenous estrogen metabolite 2-methoxyestradiol. Arthritis Rheum. 40: 154-163.
45. Gao, W., C. Zeng, D. Cai, et al. 2010. Serum concentrations of selected endogenous estrogen and estrogen metabolites in pre- and post-menopausal Chinese women with osteoarthritis. J. Endocrinol. Invest. 33: 644-649.